open access

Vol 22, No 1 (2019)
Research paper
Submitted: 2018-12-21
Accepted: 2019-01-07
Published online: 2019-01-31
Get Citation

Feasibility of myocardial perfusion imaging studies in morbidly obese patients with a cadmium-zinc-telluride cardiac camera

Anna Budzyńska1, Sebastian Osiecki1, Andrzej Mazurek1, Stanisław Piszczek1, Mirosław Dziuk1
DOI: 10.5603/NMR.2019.0003
·
Pubmed: 31482538
·
Nucl. Med. Rev 2019;22(1):18-22.
Affiliations
  1. Military Institute of Medicine, Szaserów 128 Street, 04-141 Warsaw

open access

Vol 22, No 1 (2019)
Original articles
Submitted: 2018-12-21
Accepted: 2019-01-07
Published online: 2019-01-31

Abstract

BACKGROUND: A novel cardiac SPECT camera with cadmium-zinc-telluride (CZT) based technology has a fixed array of semiconductor detectors paired with pinhole collimators focused on the heart. Image acquisition in obese patients can be challenging because of much smaller detector field of view compared to conventional gamma cameras. The aim of this study was to evaluate the impact on high body mass on the feasibility of CZT myocardial perfusion imaging (MPI). The additional aim was to investigate the mechanism of the banana-shaped/obesity artifact, as referred to in literature, and to attempt at simulating it on a phantom study.

MATERIAL AND METHODS: Study group consisted of 43 patients with morbid obesity (BMI ≥ 40 kg/m2). All these patients underwent myocardial perfusion imaging on both CZT cardiac camera and general purpose SPECT/CT gamma camera. Control group consisted of all patients who underwent myocardial perfusion imaging on CZT camera throughout one calendar year and whose BMI was lower than 40 kg/m2. In this group, all repeated studies were re-analyzed for estimating the frequency of heart mispositioning in the camera field of view. The number of studies performed was 1180. A static cardiac phantom was used to simulate a banana-shaped artifact. A series of phantom acquisitions during which the phantom position was altered in the camera field of view was performed.

RESULTS: In control group, 3.7% of all cardiac scintigrams required repetition, 18.9% of which were repeated due to wrong heart positioning; median BMI in this group of patients was 36.0. A banana-shaped artifact was observed in one female patient with BMI 36.0. In morbid obesity group, 32.6% of the studies were non-diagnostic with “truncation effect” on Scan Quality Control (QC). Median BMI in patients with diagnostic scans was 42.0, while in patients with not acceptable quality control test it was 45.0 (p < 0.05). Banana-shaped artifacts were observed in 5 non-diagnostic studies. In a phantom study an artifact of banana shape was obtained when gantry was distant from the phantom and target was on the edge of the camera field of view and was slightly truncated.

CONCLUSIONS: Problem with heart mispositioning during imaging on the CZT camera affects less than 1% of all performed studies. Morbid obesity is not a contraindication to perform myocardia

Abstract

BACKGROUND: A novel cardiac SPECT camera with cadmium-zinc-telluride (CZT) based technology has a fixed array of semiconductor detectors paired with pinhole collimators focused on the heart. Image acquisition in obese patients can be challenging because of much smaller detector field of view compared to conventional gamma cameras. The aim of this study was to evaluate the impact on high body mass on the feasibility of CZT myocardial perfusion imaging (MPI). The additional aim was to investigate the mechanism of the banana-shaped/obesity artifact, as referred to in literature, and to attempt at simulating it on a phantom study.

MATERIAL AND METHODS: Study group consisted of 43 patients with morbid obesity (BMI ≥ 40 kg/m2). All these patients underwent myocardial perfusion imaging on both CZT cardiac camera and general purpose SPECT/CT gamma camera. Control group consisted of all patients who underwent myocardial perfusion imaging on CZT camera throughout one calendar year and whose BMI was lower than 40 kg/m2. In this group, all repeated studies were re-analyzed for estimating the frequency of heart mispositioning in the camera field of view. The number of studies performed was 1180. A static cardiac phantom was used to simulate a banana-shaped artifact. A series of phantom acquisitions during which the phantom position was altered in the camera field of view was performed.

RESULTS: In control group, 3.7% of all cardiac scintigrams required repetition, 18.9% of which were repeated due to wrong heart positioning; median BMI in this group of patients was 36.0. A banana-shaped artifact was observed in one female patient with BMI 36.0. In morbid obesity group, 32.6% of the studies were non-diagnostic with “truncation effect” on Scan Quality Control (QC). Median BMI in patients with diagnostic scans was 42.0, while in patients with not acceptable quality control test it was 45.0 (p < 0.05). Banana-shaped artifacts were observed in 5 non-diagnostic studies. In a phantom study an artifact of banana shape was obtained when gantry was distant from the phantom and target was on the edge of the camera field of view and was slightly truncated.

CONCLUSIONS: Problem with heart mispositioning during imaging on the CZT camera affects less than 1% of all performed studies. Morbid obesity is not a contraindication to perform myocardia

Get Citation

Keywords

obesity, BMI, myocardial perfusion imaging, CZT, cardiac camera, image artifacts

Supp./Additional Files (1)
Abstract
Download
12KB
About this article
Title

Feasibility of myocardial perfusion imaging studies in morbidly obese patients with a cadmium-zinc-telluride cardiac camera

Journal

Nuclear Medicine Review

Issue

Vol 22, No 1 (2019)

Article type

Research paper

Pages

18-22

Published online

2019-01-31

Page views

689

Article views/downloads

723

DOI

10.5603/NMR.2019.0003

Pubmed

31482538

Bibliographic record

Nucl. Med. Rev 2019;22(1):18-22.

Keywords

obesity
BMI
myocardial perfusion imaging
CZT
cardiac camera
image artifacts

Authors

Anna Budzyńska
Sebastian Osiecki
Andrzej Mazurek
Stanisław Piszczek
Mirosław Dziuk

References (8)
  1. Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: new designs and clinical implications. J Nucl Med. 2011; 52(2): 210–217.
  2. Oddstig J, Hedeer F, Jögi J, et al. Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera. J Nucl Cardiol. 2013; 20(1): 38–44.
  3. Buechel RR, Herzog BA, Husmann L, et al. Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation. Eur J Nucl Med Mol Imaging. 2010; 37(4): 773–778.
  4. Hindorf C, Oddstig J, Hedeer F, et al. Importance of correct patient positioning in myocardial perfusion SPECT when using a CZT camera. J Nucl Cardiol. 2014; 21(4): 695–702.
  5. Fiechter M, Gebhard C, Fuchs TA, et al. Cadmium-zinc-telluride myocardial perfusion imaging in obese patients. J Nucl Med. 2012; 53(9): 1401–1406.
  6. Wąsowski M, Walicka M, Marcinowska-Suchowierka E. Otyłość – definicja, epidemiologia, patogeneza. Postępy Nauk Medycznych. 2013; XXVI(4): 301–306.
  7. Piszczek S, Osiecki S, Witkowska-Patena E, et al. The diagnostic efficacy and safety of stress-only supine and prone myocardial perfusion imaging with a dedicated cardiac gamma camera in patients with suspected or known coronary artery disease. Nucl Med Rev Cent East Eur. 2018; 21(2): 104–108.
  8. Gimelli A, Bottai M, Giorgetti A, et al. Evaluation of ischaemia in obese patients: feasibility and accuracy of a low-dose protocol with a cadmium-zinc telluride camera. Eur J Nucl Med Mol Imaging. 2012; 39(8): 1254–1261.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl